Taken together, we concluded that the over-expression of huMETCAM/MUC18 appeared to inhibit both the in vitro migration and invasiveness of the NPC-TW01 cells, and this was due to the direct effects of METCAM/MUC18. The gene discussed is MCAM; the disease is nasopharyngeal carcinoma.